Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-31

Clinical Trial Update: Metformin in Patients With Fragile X [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for metformin in Fragile X Syndrome spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Rowan University | Conditions: Fragile X Syndrome | Phase 1, Phase 2 | Status: UNKNOWN